Skip to main content

Table 2 Comparison of this assessment to baseline studies: only presenting cancers cases (except testicle)

From: Assessment of cancers’ diagnostic stage in a Deaf community - survey about 4363 Deaf patients recorded in French units

Type of cancer
(number of Deaf cases)
Stage % observed in the sample studied (nomber) % of the reference population Baseline studies
Colo-rectal (n = 6) I 25.7% PETRI (Fr) [24]
(37,413 patients)
II 21.3%
III 67% (4) 20.6%
IV 33% (2) 26.5%
NDa 5.9%
Melanoma (n = 3) I and II 86.2% PETRI (Fr) [24]
(7401 patients)
III 33% (1) 3.4%
IV 67% (2) 6.4%
NDa 4%
Hodgkin’s lymphoma (n = 3) I 81.7% PETRI (Fr) [24]
(1544 patients)
II 8.7%
III 67% (2) 3.8%
IV 3.8%
NDa 33% (1) 2.0%
Non-Hodgkin’s lymphoma (n = 4) Localized 25% (1) 30% SEER (USA) [25]
(10,224 patients)
Regional 50% (2) 15%
Metastatic 25% (1) 47%
NDa 9%
Lung (n = 3) I 15.5% PETRI (Fr) [24]
(31,557 patients)
II 33% (1) 13.6%
III 20%
IV 67% (2) 39.4%
NDa 11.5%
Prostate (n = 11) T1N0M0 9% (1) 27.4% « Cancer de la prostate en France en 2001 » [21]
(2181 patients)
T2N0M0 9% (1) 59.2%
T3/T4N0M0 46% (5) 3.0%
N + M+ 18% (2) 10.4%
NDa 18% (2)
Breast (n = 15) T1 33% (5) 66% Breast cancer incidence: Decreasing trend in large tumours in women aged 50–74 [22]
(28,092 patients)
T2+ 60% (9) 34%
NDa 7% (1)
N0 53% (8) 63%
N+ 40% (6) 33%
NDa 7% (1) 4%
M0 93% (14) 90.5%
M+ 1 (7%) 4.5%
NDa 5%
Thyroid (n = 3) I 67% (2) 67.9% PETRI (Fr) [24]
(6672 patients)
II 33% (1) 6.4%
III 9.2%
IV 9.2%
NDa 7.3%
Uterine (n = 3) Localized 67% (2) 69% SEER (USA) [25]
(5774 patients)
Regional 19%
Metastatic 33% (1) 8%
NDa 4%
  1. aND: Not Definited